您的位置: 首页 > 农业专利 > 详情页

Extended-release formulation for reducing the frequency of urination and method of use thereof
专利权人:
WELLESLEY PHARMACEUTICALS LLC
发明人:
Dill David A.
申请号:
NZ72181812
公开号:
NZ721818A
申请日:
2012.08.22
申请国别(地区):
NZ
年份:
2017
代理人:
摘要:
Disclosed is the use of a pharmaceutical composition comprising a first component formulated for immediate-release and a second component formulated for extended-release in the manufacture of a medicament for treating nocturia in a subject in need thereof, wherein said first component and said second component each comprises acetaminophen, and wherein said acetaminophen in said first component and said second component is present in an amount of 5 mg to 2000 mg, and further wherein said first component and/or said second component further comprises an antidiuretic agent such as desmopressin; and wherein said first component and/or said second component optionally further comprises an antimuscarinic agent selected from the group consisting of oxybutynin, solifenacin, darifenacin and atropine; and/or optionally further comprises one or more spasmolytics.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充